Citations

Mayo Clinic

Showing 10 of 108523 citations.

Artificial Intelligence and Health Inequities in Dietary Interventions on Atherosclerosis: A Narrative Review
Mackay, K. , Monlezun, Dominique J , MacKay, Keir , Monlezun, Dominique

Nutrients | August 8, 2024 | Volume: 16 | Issue: 16 | Pages: 2601

10.3390/nu16162601 | PMID 39203738 Get It

Poor diet is the top modifiable mortality risk factor globally, accounting for 11 million deaths annually with half being from diet-linked atherosclerotic cardiovascular disease (ASCVD). Yet, most of the world cannot afford a healthy diet—as the hidden costs of the inadequate global food system total over USD 13 trillion annually—let alone the much more clinically, financially, and ecologically costly and resource-intensive medical interventions required to address the disease progression and acute complications of ASCVD. Yet, AI is increasingly understood as a force multiplying revolutionary technology which may catalyze multi-sector efforts in medicine and public health to better address these significant health challenges. This novel narrative review seeks to provide the first known overview of the state-of-the-art in clinical interventions and public health policies in healthy diets for ASCVD, accelerated by health equity-focused AI. It is written from the first-hand practitioner perspective to provide greater relevance and applicability for health professionals and data scientists. The review summarizes the emerging trends and leading use cases in population health risk stratification and precision public health, AI democratizing clinical diagnosis, digital twins in precision nutrition, and AI-enabled culinary medicine as medical education and treatment. This review may, therefore, help inform and advance the evidence-based foundation for more clinically effective, financially efficient, and societally equitable dietary and nutrition interventions for ASCVD.
Optimizing Access in Hip Arthroscopy
Richardson, Meghan W., Goodloe, J. Brett , Gwathmey, F. Winston , Su, Charles A.

Video Journal of Sports Medicine | August 8, 2024 | Volume: 4 | Issue: 4 | Pages: No page available

10.1177/26350254241241080 | PMID 40309055 Get It

Background: Arthroscopic access to the hip can be challenging. We present a reproducible, safe, and efficient method for arthroscopic access to the hip. This can be especially beneficial for hips that may be predisposed to more difficult access. Indications: Hip arthroscopy is indicated in patients with symptomatic femoral acetabular impingement (FAI) who have failed conservative treatment options. FAI surgery aims to address both bony impingement and labral pathology in the hip. Technique: In this technique, we describe methodical steps to hip access. These steps include special attention to patient positioning and preoperative radiographs, air arthrogram, bevel control for needle joint entry, careful interpretation of intraoperative fluoroscopy, and adequate capsulotomy for viewing. Results: The majority of patients undergoing hip arthroscopy for FAI have improvements in both hip function and pain. Preoperative findings of increased center edge angle and male sex may predispose patients to more difficult hip arthroscopy access. The use of this technique may aid in reproducible access. Discussion/Conclusion: Hip arthroscopy is a good option for patients who have failed conservative treatment options and have signs and symptoms of FAI. Reproducible, safe, and efficient access to the hip is critical to starting hip arthroscopy cases. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
Tissue Ablation: Applications and Perspectives (Adv. Mater. 32/2024)
Çevik, Enes , Demirlenk, Yusuf Mert , Atar, Dila , Saini, Gia , Sheth, Rahul A. , Keum, Hyeongseop , Kim, Jinjoo , Deipolyi, Amy R. , Öklü, Rahmi

Advanced Materials | August 8, 2024 | Volume: 36 | Issue: 32 | Pages: No page available

10.1002/adma.202470259 Get It

Another Vital Reason to Treat Hypertension: Preventing Intracranial Artery Dissections
Keser, Zafer , Keser, Zafer

American Journal of Hypertension | August 8, 2024 | Volume: 37 | Issue: 12 | Pages: 943-944

10.1093/ajh/hpae104 | PMID 39110033 Get It

Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers
Ellison, Gary L. , Helzlsouer, Kathy J. , Rosenfield, Sonia , Cullen, Jennifer, Doran, Neal , Ebbert, Jon O. , Egan, Kathleen M. , McDaniels‐Davidson, Corinne , Hernandez-Ortega, Nicholas, Salz, Talya , Vidot, Denise C , Zylla, Dylan M. , Rosenfield, Sonia M , Doran, Neal , McDaniels-Davidson, Corinne , Kim, Yun , Ashare, Rebecca L. , Blaes, Anne , Heffner, Jaimee L. , Lee, Richard T. , McClure, Erin A. , Meghani, Salimah H. , Newcomb, Polly A. , Nugent, Shannon M. , Worster, Brooke K. , Zylla, Dylan

JNCI Monographs | August 7, 2024 | Volume: 2024 | Issue: 66 | Pages: 202-217

10.1093/jncimonographs/lgae029 | PMID 39108244 Get It

Abstract Background The legal climate for cannabis use has dramatically changed with an increasing number of states passing legislation legalizing access for medical and recreational use. Among cancer patients, cannabis is often used to ameliorate adverse effects of cancer treatment. Data are limited on the extent and type of use among cancer patients during treatment and the perceived benefits and harms. This multicenter survey was conducted to assess the use of cannabis among cancer patients residing in states with varied legal access to cannabis. Methods A total of 12 NCI-Designated Cancer Centers, across states with varied cannabis-access legal status, conducted surveys with a core questionnaire to assess cannabis use among recently diagnosed cancer patients. Data were collected between September 2021 and August 2023 and pooled across 12 cancer centers. Frequencies and 95% confidence intervals for core survey measures were calculated, and weighted estimates are presented for the 10 sites that drew probability samples. Results Overall reported cannabis use since cancer diagnosis among survey respondents was 32.9% (weighted), which varied slightly by state legalization status. The most common perceived benefits of use were for pain, sleep, stress and anxiety, and treatment side effects. Reported perceived risks were less common and included inability to drive, difficulty concentrating, lung damage, addiction, and impact on employment. A majority reported feeling comfortable speaking to health-care providers though, overall, only 21.5% reported having done so. Among those who used cannabis since diagnosis, the most common modes were eating in food, smoking, and pills or tinctures, and the most common reasons were for sleep disturbance, followed by pain and stress and anxiety with 60%-68% reporting improved symptoms with use. Conclusion This geographically diverse survey demonstrates that patients use cannabis regardless of its legal status. Addressing knowledge gaps concerning benefits and harms of cannabis use during cancer treatment is critical to enhance patient-provider communication.
Evaluation and Management of Pelvic Osteomyelitis in Stage IV Pressure Injuries: A Multidisciplinary Collaborative Approach
Zein, Said El , Melin, Matthew M , Tran, Nho V. , Rose, Peter S. , Berbari, Elie F. , El Zein, Said , Suh, Gina A.

Clinical Infectious Diseases | August 7, 2024 | Volume: 79 | Issue: 3 | Pages: e11-e26

10.1093/cid/ciae394 | PMID 39325647 Get It

Abstract Managing pelvic osteomyelitis (POM) in the setting of stage IV pressure injuries requires multidisciplinary evaluation as well as patient and caregiver engagement and is complicated by the lack of high-evidence data to guide best practices. In this review, we describe our approach to pressure injury and POM evaluation and management through multidisciplinary collaboration and highlight areas of future research that are necessary to enhance patient outcomes, reduce healthcare costs, and improve the quality of life of those affected by POM.
Nodular regenerative hyperplasia: The role of the CK7 immunohistochemistry pattern of expression in diagnosis
Bartow, Brooke B., Dhall, Deepti, Lee, Goo , Garapati, Manjula, Patel, Chirag , Diffalha, Sameer Al , Patel, Chirag R

American Journal of Clinical Pathology | August 7, 2024 | Volume: 163 | Issue: 2 | Pages: 196-204

10.1093/ajcp/aqae110 | PMID 39213447 Get It

Abstract Objectives Nodular regenerative hyperplasia (NRH) is a rare vascular disorder of the liver. Clinically, patients present with portal hypertension with or without a cholestatic pattern of injury. Histologically, the liver parenchyma is composed of small nodules of hypertrophic hepatocytes surrounded by atrophic hepatocytes without significant fibrosis. Nodular regenerative hyperplasia is a difficult diagnosis on biopsy specimens, but biopsy remains the gold standard for diagnosis. In this retrospective review, cytokeratin 7 (CK7) immunohistochemistry (IHC) was used to aid in the diagnosis and further characterization of NRH and NRH-like changes. Methods The H&E-stained slides, reticulin, and CK IHC were reviewed for 22 cases. The percentage of hepatocytes staining for CK7 (0%-100%), the location of staining (centrilobular hepatic progenitor cells vs periportal/bile ductular reaction), and the pattern of staining distribution (patchy or diffuse) were recorded for comparison. Results Of the 22 cases, 9 were CK7 positive. Cases of NRH, however, expressed various degrees of CK7 positivity in centrilobular hepatic progenitor cells, unlike NRH-like changes, which were either CK7 negative or CK7 positive in periportal hepatocytes or in areas of bile ductular reaction. Conclusions In cases with the appropriate clinical history and histology, CK7 immunohistochemistry can be performed to distinguish nodular regenerative hyperplasia (primary) and NRH-like changes (secondary). In difficult cases, CK7 positivity in centrilobular hepatic progenitor cells can help confirm the diagnosis of NRH. These data support NRH as a true entity with a distinct pathophysiology from NRH-like changes.
“Down Syndrome is Not a Curse”: parent Perspectives on the Medicalization of Down Syndrome
Riggan, Kirsten A. , Michie, Marsha , Allyse, Megan , Allyse, Megan A , Riggan, Kirsten A

AJOB Empirical Bioethics | August 7, 2024 | Volume: 16 | Issue: 1 | Pages: 10-21

10.1080/23294515.2024.2388533 | PMID 39110899 Get It

“Genetic tumor syndromes of the head and neck: Update in the genomic era”
Brahmbhatt, Sneh , Shetty, Dhruv , Bhatt, Alok A. , Bhatt, Alok A , Agarwal, Amit , Desai, Amit

The Neuroradiology Journal | August 7, 2024 | Volume: 38 | Issue: 3 | Pages: 277-290

10.1177/19714009241269462 | PMID 39110991 Get It

Genetic tumor syndromes are due to inherited genetic mutations, which have recently come to the attention of clinicians due to the widespread adoption of DNA sequencing, ultimately leading to imaging for surveillance. As a result, radiologists must be familiar with the clinical, genetic, and radiologic features of these syndromes. This article reviews genetic tumor syndromes of the head and neck according to the recently updated WHO’s 5th edition.
Abstract 460: Adventitial Delivery of Nanoparticle Hydrogel-calcitriol Attenuates Restenosis in a Murine Angioplasty Model
Zhao, Chenglei , Singh, Avishek , Misra, Avanish, Simeon, Michael L. , Li, Yiqing , Cai, Chuanqi , Kilari, Sreenivasulu , Misra, Sanjay

Arteriosclerosis, Thrombosis, and Vascular Biology | August 7, 2024 | Volume: 40 | Issue: Suppl_1 | Pages: No page available

10.1161/atvb.40.suppl_1.460 Get It

Background: Percutaneous transluminal angioplasty (PTA) is the first-line treatment for arteriovenous fistula (AVF) failure and immaturation. High rate of restenosis occurs post PTA procedure caused by venous neointimal hyperplasia (VNH), and decrease the durability of it. Failed AVF showed increased gene expression of Ier3. Poly lactic- co -glycolic acid nanoparticles (PLGA) loaded with 1,25-dihydroxyvitamin D 3 (1,25 NP) can inhibit Ier3 gene expression. Hypothesis: Adventitial delivery of 1,25 NP in hydrogel will reduce venous stenosis in a murine PTA model. Methods: Male C57BL/6J mice underwent partial nephrectomy at day -42 and arteriovenous fistula (AVF) creation at day -14. At day 0, mice were randomized to vehicle group (PTA + PLGA hydrogel) or treatment group (PTA + 1,25 NP hydrogel). Mice were euthanized at day 3 for gene expression analysis and at day 21 for histopathological analysis. Doppler ultrasound was performed weekly to evaluate AVF patency and function. Results: At day 3, PTA + 1,25 NP treated vessels had a significant decrease in the gene expression of Ier3 compared to controls. At day 21, 1,25 NP treated outflow veins had increased lumen vessel area, apoptosis, and higher peak systolic velocity, but decrease in neointimal area/media area ratio, fibroblasts, pro-inflammatory macrophages (M1), fibrosis (picrosirius red staining) and cellular proliferation. Conclusion: Adventitial delivery of 1,25 NP plus PTA has the ability to reduce restenosis and VNH formation. This protective effect is related to inhibition of Ier3 gene expression which modulates vascular inflammation and fibrosis post PTA.